FDA Webview
X
Search
Log In
Home
About Us
Today@FDA
Pay Per View
Free Trial
Contact Us
More
▼
Tell Friend
Subscribe
View Order
Title
Price
Tenaxs TNX-103 Misses Primary Endpoint in Phase 3 Trial
$ 8.95
FDA Webview Free Daily e-Newsletter
Free Sign-Up